Clinical trial
Acetylcarnitine and Insulin Sensitivity
NCT00393770 · Mario Negri Institute for Pharmacological Research, Other · Completed
Key facts
| NCT number | NCT00393770 |
|---|---|
| Title | Acetylcarnitine and Insulin Sensitivity |
| Official title | A Pilot Study to Evaluate the Short-term Effects of Acetyl-carnitine on Insulin Resistance and the Metabolic Syndrome in Patients at Increased Risk of Type 2 Diabetes: Acetyl-carnitine in Insulin Resistance |
| Lead sponsor | Mario Negri Institute for Pharmacological Research, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | L-acetylcarnitine |
| Enrollment | 43 |
| Start date | Feb 1, 2004 |
| Primary completion | Oct 1, 2006 |
| Completion | Sep 1, 2007 |
| First posted | Oct 30, 2006 |
| Last update posted | Jun 10, 2011 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: